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Abstract

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Background of the study: 
Diabetes Mellitus is often associated with a number of medical 
complications as a result of the metabolic changes taking place systemically. There 
is considerable evidence it is also associated with oral health complications 
including gingivitis, periodontitis, xerostomia, oral candidiasis, dental caries, ulcers  
lichen  planus, burning mouth syndrome and an altered taste sensation . 
Aim:
To study various types of oral health complications in Type 2 diabetes 
mellitus patient visiting a dental college in Kanyakumari District.   
Materials & Methods: 
A comparative cross-sectional study to determine the common oral 
complications prevalent in diabetics and non-diabetics was carried out in the 
outpatient department and the study sample consisted of 127 diabetic patients and 
127 non diabetic patients. The oral health status was assessed clinically for each 
patient and recorded. The data was analysed by Statistical Package for Social 
Sciences (SPSS 16.0). Chi square test was applied to find the statistical significance 
between the groups. 
Results:
The most frequent manifestation observed in diabetic patient was 
periodontitis followed by oral candidiasis, oral burning sensation, altered taste and 
hyposalivation. Most common mucosal disorders observed is geographic tongue 
followed by hyperpigmentation.  The result correlated well with other studies. 
..
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Conclusion:
It is concluded that the oral cavity exhibits the first sign of an undiagnosed or 
uncontrolled diabetes, hence oral health care providers must be well aware of signs 
and symptoms to refer such to a physician for further investigation as well as 
manage and treat the oral health complications. 
Keywords: Diabetes Mellitus, Type II, Hyperglycemia, Oral Health complications. 


























INTRODUCTION
Introduction 

 
The earliest description of diabetes was documented in the writings of Hindu 
scholars as long as in 1500 BC. They had already described “a mysterious disease 
causing thirst, enormous urine output, and wasting away of the body with flies and 
ants attracted to the urine of people.” The term diabetes was probably coined by 
Apollonius of Memphis around 250 BC, which literally meant “to go through” or 
siphon as the disease drained more fluid than a person could consume. Later on, the 
Latin word “mellitus” was added by Thomas Willis  because it made the urine 
sweet.  In 1776  Dobson  first mentioned the presence of increased sugar content in 
urine and blood as a cause of this sweetness. An important milestone in the history 
of diabetes is the establishment of the role of the liver in glycogenesis, and the 
concept that diabetes is due to excessive glucose production which was stated by 
Claude Bernard  in 1857. The role of the pancreas in pathogenesis of diabetes was 
discovered by Mering and Minkowski in 1889. This discovery formed the basis of 
insulin isolation and clinical use of it by Banting and Best in 1921. Trials were 
conducted to prepare an orally administrated hypoglycemic agent which resulted in 
sucess by first marketing of tolbutamide and carbutamide in 1955.1
Diabetes mellitus or simply diabetes is considered as a syndrome of 
disordered metabolism with abnormally high blood glucose levels (hyperglycemia).2
Diabetes mellitus (DM) is described as one of the most common endocrine diseases 
in medicine3,4,5 or the most common chronic disorder.6 Diabetes Mellitus 
encompasses a heterogeneous group of disorders with the common characteristic of 
altered glucose tolerance and impaired   lipid and carbohydrate metabolism.7
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In 2014 the global prevalence of diabetes was estimated to be 387 million 
people with  Type 2 DM making up about 90% of the cases. This represents 8.3% of 
the adult population, with equal rates in both women and men. In 2012, an estimated 
1.5 million deaths were directly caused by diabetes.8 More than 80% of diabetes 
deaths occur in low- and middle-income countries.8  WHO projects that diabetes 
will be the 7th leading cause of death in 2030.9 The number of diabetic individuals is 
increasing  globally because of population growth, ageing, increasing prevalence of 
obesity, urbanization ( stress and lifestyle). 
The two most common forms of diabetes are Type 1 diabetes (diminished 
production of insulin) and Type 2 diabetes (impaired response to insulin and b-cell 
dysfunction). Both lead to hyperglycemia, excessive urine production, compensatory 
thirst, increased fluid intake, blurred vision, unexplained weight loss, lethargy, and 
changes in energy metabolism. A third type , Gestational diabetes mellitus (GDM) 
which is defined as any degree of glucose intolerance with onset or first recognition 
during pregnancy. Approximately 7% of all pregnancies are complicated by GDM, 
resulting in more than 200,000 cases annually.10 
Diabetes is a chronic pernicious disorder of the carbohydrate, fat and protein 
metabolism11, 12 and is regarded as a true metabolic disorder, which produces  
pathological changes in every tissue of the body.Oral physicians can play a major 
role in identifying a diabetic  patient, as diabetes is associated with several oral 
complications because  elevated blood glucose levels  affects almost all body tissues 
including the oral cavity.  A series of alterations occurs in the oral mucosa  and also 
periodontal health will been compromised in uncontrolled diabetic patients .                   
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AIMS
 To study various types of oral health complications in Type 2 diabetes 
mellitus patient visiting a dental college in Kanya Kumari District.   
OBJECTIVES 
1) To evaluate the stomatology changes in diabetics as compared to non diabetics 
controls.
2) To compare stomatological changes between controlled and uncontrolled 
diabetic patients.
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The objective of this review is to provide  an overview of diabetes in terms 
of its classification,  risk factors, pathophysiology, diagnosis and management. The  
common oral complications observed in diabetics  are discussed as well as the role 
of dentists  in  diagnosis and management of oral complications in  a diabetic patient 
is also reviewed here.  
Diabetes is a clinical syndrome caused by a relative or absolute insulin 
deficiency which causes irregularities of carbohydrate, protein and lipid 
metabolisms.13 It is pernicious in nature and has strong and well established 
assosiations with numerous co-morbid conditions. Its most important feature is 
hyperglycaemia that can result from decreased insulin production or insulin 
dysfunction or lack of insulin receptor responsiveness at target organs.6,14,3 
CLASSIFICATION OF DIABETES 
The classification of Diabetes Mellitus is based on pathogenic processes 
which leads to absolute  or  relative insulin deficiency, leading to hyperglycaemia, a 
important  feature of diabetes.15 It is grouped broadly into three categories based on  
its signs and symptoms, namely Type 1, Type 2 and gestational diabetes that occur 
in pregnant women.16 Type 1 usually has its early onset in childhood and 
adolescence and is only prevalent among 5-10% of total diabetic population.15 The 
term Type 1 diabetes has replaced what previously known as insulin dependent 
diabetes mellitus (IDDM), juvenile-onset diabetes mellitus (JODM) and early onset 
diabetes.4 The previous names were used because Type 1 diabetics  needed insulin 
for life and usually the disease occurred before 30 years of age. The new 
classification is an attempt to introduce accurate, proper terminology and  also to 
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provide a functional  and working classification of diabetes that reflects the current 
knowledge about the disease rather than a  classification based on treatment 
methodology.4 
  The American Diabetes Association recommends that Type 1 DM is to be 
further divided into Type 1A and Type 1B.4 Type 1A is caused by cell-mediated 
autoimmune destruction of the beta cells of the pancreas while Type 1B refers to 
non immune mediated diabetes (NIMD) with severe insulin deficiency. Type 1B is 
mainly found in  of Asian or African population. The characteristic features of this 
type are very similar to those of Type 2 DM which are ketoacidosis and absence of 
autoimmune markers.4,17 
 Type 1 diabetes is a slowly progressive T-cell-mediated autoimmune disease, 
although its has ab abrupt onset.17,18 This type of diabetes  occurs in very young 
individuals less than 30 years,  who are mostly adolescent or children.In Type 1 
diabetes, the beta cells of the Islets of Langerhans in the pancreas are destroyed and 
are unable to produce insulin3,16 which  results in a cascade of metabolic reactions 
that manifests as complications associated with diabetes. Hyperglycaemia, 
accompanied by the features of diabetes occurs only when 70-90% of the beta cells 
have been destroyed and together with familial studies has served as proof that this 
Type of diabetes has a very slow-onset.18  
Insulin is pivotal for glucose metabolism and the human body cannot 
function properly in its absence, as it is unable to transport glucose to the cells where 
it is required. It facilitates the entry of glucose that is absorbed by blood into the 
cells of the body by using  glucose transporters.19 Hence  external insulin therapy is 
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given to all Type 1 diabetic patients to prevent the build-up of glucose in the tissue 
fluids and blood stream.3 
Type 1 diabetes most oftenly predisposes patients to a condition known as 
diabetic ketoacidosis (DKA). DKA occurs due to poor insulin control and it also 
interferes with bone coupling and healing.20 When glucose cannot enter the 
bloodstream, fat metabolism occurs through lipolysis and is  glycerol and free fatty 
acids are released as end products. The glycerol is converted to glucose and the fatty 
acids into ketones which then accumulate in the body fluids. A slowly evolving 
variant of Type 1 diabetes is known as latent autoimmune diabetes in adults 
(LADA). This Type can be detected by specific auto antibodies called glutamic acid 
decarboxylase (GAD) the GAD65Ab being specifically associated with LADA in 
middle-aged people.18 This subgroup is often masked as Type 2 diabetes until 
evidence of autoimmune activity against pancreatic beta cells is discovered.  
Type 2 is the most common form of diabetes 21,3,5  and is refered to non-
insulin dependant diabetes mellitus. It occurs as a result of a reduced responsiveness 
to insulin or insulin resistance of the target organs leading to a cascade of 
complications which includes various systemic complications like  retinopathy,  
vascular degeneration, neuropathy and nephropathy. It is well accepted  fact that 
there is excessive production of glucose in the liver accompanied by under 
utilization of glucose in the skeletal muscle results from resistance to the actions of 
insulin .18This Type has its onset in people aged 40 years  and above.15 
In both types of DM, the vascular system where the exchange of oxygen, 
nutrients and waste products occurs, is affected. The capillaries can be affected in 
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two ways: either it can be damaged due to atheromatous deposits accumulating in 
the lumen of the blood vessels  or may develop a thickening of the basement 
membrane which reduces the functionality of leukocytes. The reduction in the 
activity of leukocytes leads to decreased polymorphoneucleocytes’ (PMNs) killing 
ability making the diabetic patient more vulnerable to severe infection than a non-
diabetic patient.19,20 
The accompanying hyperglycemia causes advanced glycation end products 
(AGEs) and the release of glycoheamoglobin (HgbA1c) that also contributes to the 
thickening of the basement membrane of the blood vessels. Unlike hemoglobin, the 
glycoheamoglobin is less adept when it comes to transportation of oxygen. Other 
pathological mechanisms associated to elevated hyperglyceamia are activation of the 
sorbitol pathway, damaging effects of oxidative stress and altered lipid 
metabolism.22 
Diabetes Mellitus affects the entire body. Tissues affected are those rich in 
blood vessels like the kidney, retina and nerves23  because of which complications 
such as neuropathy ,renal disease , retinopathy, peripheral vascular disorders and 
coronary disease  occurs.19 These complications are associated with long-term 
fuctional and biochemical abnormalities which occurs in poorly controlled diabetes 
and  often leads to premature  increased morbidity and mortality. This occur as a 
local response to the generalized vascular damage due to vascular permeability.18 At 
present the annual mortality rate in adult diabetic patients is double that of non-
diabetic adults because of these associated complications . Myocardial infarction is 
the most common cause of death in Type 2 diabetes mellitus.5  Literatures shows that 
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women have a significantly higher risk of morbidity and mortality as a result of 
diabetes associated complications.24 
Gestational diabetes is defined as either onset or first recognition of glucose 
intolerance during pregnancy in a woman that has not had this condition before.16,25 
The onset is during the third trimester.14 It is a pernicious condition and is 
responsible for perinatal morbidity and mortality as it is closely linked to pre-
eclampsia, caesarian delivery, premature rupture of membranes and preterm 
delivery. 25 Its  pathophysiology resembles  that of Type 2 diabetes as it is  also 
associated with increased insulin resistance. 
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Table 1   
Classification of Diabetes Mellitus 26 
 
Risk Factor  
Risk factors for diabetes can be broadly classified into modifiable and non-
modifiable. The non-modifiable factors  includes  genetic predisposition, increasing 
age and ethnicity.27 Diabetes Mellitus is associated with familial history , although 
the mode of inheritance of the susceptible genes is rather elusive.27  
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Modifiable risk factors includes obesity, sedentary lifestyles, hypertension, 
smoking and increased cholesterol levels. Changing lifestyles with little or no 
exercise and a high fat diet lacking in fibre  significantly contributes to obesity.27 
Obesity (with  BMI >30) is a major risk factor for Type 2 diabetes as it plays a very 
significant role in the patho-physiology of diabetes. Obesity is an integral part of 
metabolic syndrome X and it predisposes to Type 2 diabetes.3 Knowledge of risk 
factors is essential for non pharmacological  management  of diabetes. Diabetes 
often enhances the effects of other major cardiovascular  disorder  risk  factors  like 
smoking, hypertension and hyperlipidaemia.18 Hence diabetic patients should 
receive some form of  dietary and lifestyle  counselling, and should be strongly 
discouraged from smoking and unhealthy eating habits.  
Other modifiable risk factors particular for diabetes mellitus are impaired 
glucose tolerance (IGT) and impaired fasting glucose (IFG). Both these conditions 
are referred to as pre-diabetes. The factors refers to a state that exists between 
diabetes and normoglycemia.3  People with this condition appear to have worse 
cardiovascular prognosis especially those with IGT.27  To diagnose pre-diabetes, a 
glucose tolerance test (GTT) has to be done. First, the blood glucose levels are 
measured after the patient has been fasting from the previous night (nearly 8 hrs). 
The patient is  then given an oral dose of glucose and the test is done  minutes to 
hours there after. A fasting glucose value of 100-125mg/dl as well as a post-glucose 
challenge of 140-199mg/dl is used to define IFG and IGT respectively.27  If a patient 
is non-diabetic the blood glucose level rises moderately and returns to normal ranges 
within an hour. In diabetic patients the blood glucose levels rise abnormally and 
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remain elevated for hours after the oral dose of glucose. The reasons for the 
prolonged hyperglycaemia could either be attributed to a lack of insulin release by 
the pancreas or impaired target tissue response to insulin or both.11 They are the 
important risk factors for developing diabetes in the future because prediabetes 
phase represents an active and destructive phase where there is progressive beta cell 
deterioration and insulin resistance occurs. 
Pathogenesis of Type 2 Diabetes Mellitus 
Type 2 diabetes mellitus is preceded  by resistance to insulin and the target 
tissues have a decreased response to the normal levels of circulating insulin.15 
Patients with Type 2 diabetes have a slow-onset of relative insulin deficiency . This 
results in more insulin required by the target tissues.  
The genetic predisposition for Type 2 diabetes is much stronger than for 
Type 1 diabetes.15 It was observed that genes involved in carbohydrate, lipid and 
amino acid metabolism pathways, glycan of biosynthesis, metabolism of cofactors 
and vitamin pathways, ubiquitin mediated proteolysis, signal transduction pathways, 
neuroactive ligand-receptor interactions, nervous system pathways and 
neurodegenerative disorder pathways are upregulated in obesity compared to health 
subjects. It was also identified that genes involved in signal transduction, regulation 
of actin cytoskeleton, complement and coagulation cascades were upregulated in 
subjects with Type 2 diabetes.28  
In these patients hyperglycaemia develops gradually over a long period and 
the renal threshold (capacity of renal tubules to reabsorb glucose from the 
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glomerular filtrate) for glucose rises, so that osmotic symptoms (polyuria and 
polydypsia) are usually mild.18 Type 2 DM is also associated with dyslipidaemia. 
Obesity and Type 2 diabetes are characterized by chronic oxidative stress and 
inflammatory stress.29  
 Establishing the diagnosis of diabetes 
Diagnosing  Diabetes Mellitus is the realm of the physician4 as oral health 
care providers  are not qualified to make a diagnosis.12 But, it is still important for 
dentists to understand how the diagnosis is reached since they have a significant role 
to play in identifying the persons at risk or  those who may have undiagnosed DM. 
The American Diabetes Association supports  the screening of all those who are at 
risk for diabetes and all those  above age of 45.27 
Several tests can be employed in order to diagnose DM but the main 
methods are fasting venous plasma glucose levels and oral glucose tolerance tests. 
Generally, a fasting glucose test is used as a way of screening patients but it remains 
limited since it cannot detect all forms of diabetes. A fasting glucose of 126 mg /dl 
or more is used to identify a diabetic patient.27 A post oral glucose challenge value 
of 200 mg/ dl or more can also identify a diabetic patient. When the above tests 
aredone and a patient is identified with diabetes, the next step is to do an oral 
glucose tolerance test (OGTT) for those who had impaired fasting glucose or in a 
high-risk individual with a normal fasting glucose. In the past, oral glucose tolerance 
test used to give false positive results as a result of stress-induced adrenaline release 
which impairs the response to glucose loading hence this test is not as popular.3 For 
this test the readings are taken twice; one reading at baseline and another 2 hours 
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after ingesting a 75g load of glucose. Should two abnormal readings be taken on 
different days then it’s undeniably a case of diabetes.27  
Glycated haemoglobin provides an accurate and objective measure of 
glycaemic control over a period of 2 months .It is  used to assess level of glycaemic 
control, but is not sufficiently sensitive to make a diagnosis of diabetes. The non-
enzymatic covalent attachment of glucose to Hb (glycation) increases the amount in 
the HbA1c fraction relative to non glycated adult. The rate of formation of HbA1c is 
directly proportionally to the blood glucose concentration ; a rise in 1% of HbA1c 
corresponds to an increase of 2 mmol/l in blood glucose. HbA1c concentration 
reflects blood glucose over the erythrocyte lifespan which is 120 days, but is 
affected more by recent events. HbA1c estimates may be diminished in anemia and 
pregnancy and may be difficult to interpret in uremia and haemoglobinopathy. In 
clinical practice  it is measured once or twice yearly to assess glycaemic control and 
provides an index of risk for developing diabetic complications.18 
MANAGEMENT
Primary aim in management of diabetes mellitus is to keep blood glucose 
levels as close to normal as possible in order  to prevent microvascular and 
macrovascular complications of diabetes. Although no total cure exists for diabetes, 
the disease  and its complications can be prevented, delayed and managed by 
identifying risk factors and detecting the condition at an early stage.30 Diabetic 
complications and progression there of is much slower with good glycemic control 
and also effective treatment of hypertension, irrespective of the type of therapy 
instituted . There are different methods of treatment that can be used to treat diabetes 
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ranging from diet modification and lifestyle changes, oral antidiabetic drugs to 
insulin.18 
                  Oral hypoglycemic medications depend on functioning pancreatic beta 
cells to stimulate insulin secretion and  therefore, are used to treat many patients 
with type 2 diabetes.3  Insulin is required for patients with type 1 diabetes, as well as 
for patients with type 2 diabetes who do not respond to oral therapy alone or in 
combination.15  Diet and physical exercise also constitute  a necessary component of 
therapy for patients with both type 1 and type 2 diabetes. 
Oral physicians should be familiar with the medications used for 
diabetes.12,31 Oral hypoglycemic agents include sulfonylureas (which enhance 
insulin secretion), biguanides (which reduce hepatic glucose production), alpha-
glucosidase inhibitors (which delay glucose adsorption) and thiazolidinediones 
(which enhance insulin sensitivity). Insulin is available in short-acting (1 to 1 
1/2hours), regular-acting (four to six hours),intermediate-acting (eight to 12 hours) 
and long-acting (24-36 hours) formulations. Insulin pumps provide a continuous 
burst of insulin to help control serum glucose levels. 
Home glucose monitoring is recommended several times daily to help 
patients to monitor glycemic levels. Many tools are available to help people with 
diabetes, including home-based urine and blood tests and glucometers. Patients must 
undergo regular examinations by physicians to monitor triglyceride, fasting glucose 
and HbA1c levels. Oral Health care providers should always document their 
patients’ most recent home-based glucose and laboratory test results, and monitor 
blood pressure levels in the dental office to avoid complications. Nutritional 
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supervision is a critical component of diabetes management, and oral physicians can 
assist in this endeavour. Risk factors for impaired nutritional intake include 
gingivitis and periodontitis, oral microbial infections, poorly fitting or lack of 
removable prostheses, dysphagia and salivary dysfunction. A realistic nutritional 
plan that includes  regular oral hygiene and requisite dental treatment can help 
patients maintain good blood glucose control and nutritional status. 32,33               
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DIABETES AND THE ORAL HEALTH STATUS 
The oral complications of uncontrolled DM may include, but are not 
essentially limited to infections , poor healing, increased incidence and severity of 
caries, candidiasis, gingivitis and periodontal disease, periapical abscesses, 
xerostomia, altered taste and burning mouth. The oral complications are most likely 
due to excessive dehydration (polyuria), the altered response to infection, the 
microvascular changes and possibly the increased glucose concentrations in saliva. 
Careful evaluation of glycaemic control is critical in determining the risk assessment 
for progression to the oral complications from diabetes. Diabetes causes changes in 
periodontal tissues, oral mucosa, salivary gland function ,oral neural functions and 
increased risk of caries . Changes  in oral soft tissues in addition to periodontium can 
aid in detecting diabetes in undiagnosed patient .34,35 
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Hyposalivation and Salivary gland changes 
The oral manifestations of diabetes in the salivary glands include 
sialoadenosis or non inflammatory, non-neoplastic enlargement of the parotid 
salivary glands,36,37 decreased salivary flow rates and changes in salivary 
composition. The enlargements are caused by gradual accumulation of fat in the 
glands, hypertrophy of the acini or secreting units, and, eventually, impaired 
glandular secretion.34 These structural changes may be the result of alteration in 
autonomic neuroregulation of the glands and atrophy of the myoepithelial cells that 
facilitate secretion. Xerostomia, or sensation of dry mouth is commonly reported 
complication in diabetics which is due to decrease in  flow of saliva because of 
autonomic nerve dysfunction or microvascular changes that diminish the ability of 
salivary glands to respond to neural or hormonal stimulation.38,39 Other causes 
include medication used in treatment and dehydration.40 
Mucosal Disorders  
Oral mucosal lesions commonly noticed in diabetics include candidiasis, 
lichen planus, lichenoid mucositis which are attributed to chronic salivary 
hypofunction and to generalised immune dysfunction seen in such patients.41,42 
 Tongue Abnormalities 
Complete or patchy atrophy of tongue papilla results in the appearance of a 
bald tongue is more commonly found in diabetics.42 Focal areas of atrophy may 
indicate an infection with candida organisms while generalized atrophy of papilla of 
the tongue has been attributed to nutritional deficiencies.43  Another manifestation 
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noted is fissuring of tongue , the smooth texture of the dorsum is interrupted with 
one or more fissures that are predominantly aligned along  length of the tongue. The 
fissuring  is due to chronic hyposalivation that alters the environment in the oral 
cavity such that slow healing soft tissues are more easily traumatized in diabetics.41 
Another observation noted in the tongue of diabetics is median rhomboid glossitis 
ssen in the dorsal aspect in the midline region which is usually smooth and flat . It is 
a recognised manifestation of chronic candidiasis.41 Another condition of the tongue 
that is more common in diabetics is geographic tongue, characterized as 
inflammation and is associated with similar symptoms of pain , itching and burning 
of the mucosa.44 
Oral Candidiasis
The combination of a decresed flow rate and immune dysfunction greatly 
increases the risk of opportunistic fungal diseases like oral candidiasis and combined 
with increased salivary glucose levels which promotes  the growth of Candida.42 
Typically patients complaints of a burning sensation of mucosa , some patients can 
be asymptomatic too. White area on mucosal surface that can be wiped off leaving a 
reddened bleeding surface is acute pseudomembraneous candidiasis. Denture 
stomatitis is diffuse redness of mucosa occurring under upper dentures in edentulous 
patients. This is considered to be a form of candidiasis where organism actually 
infects the porous denture acrylic and causing contact hypersensitivity inflammation 
of the adjacent mucosa.45 Angular chelitis is redness or fissures at the corners of the 
mouth involving the junction of the mucosa and skin and may also represent a form 
of candidiasis.34 
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Oral lichen Planus and Lichenoid Drug reaction 
It is a chronic subepithelial inflammatory disorder that results in a 
characteristic lacey or patch-like white pattern over reddened mucosa which has got 
increased prevalence in diabetics.44 Similar mucosal changes called lichenoid drug 
reactions occur as an adverse side effect to medications that diabetic patients are 
commonly prescribed.46 Lichen planus or lichenoid reactions may be symptomatic 
with pain, burning sensation, and sensitivity to acidic foods.35 
Burning Sensation of the Oral Cavity 
Burning sensation is a frequent complaint in diabetic patients, making 
diabetes the systemic condition most frequently associated with this symptom. a 
neuropathic basis is supported by observations that the burning sensations in 
diabetic patients are frequently accompanied by changes in taste (dysgeusia) or other 
sensory distortions.47  Patients with peripheral diabetic neuropathy are more likely to 
have burning sensations in oral tissues than those without peripheral neuropathy. 
Also altered taste has been attributed to early manifestation of diabetic 
neuropathy.48,49 
Dental Caries 
The literature presents no consistent pattern regarding the relationship of 
dental caries and diabetes though a reduction in salivary flow has been reported in 
people with diabetes who have neuropathy which is a risk factor for dental caries.50  
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Periodontitis
Diabetes has been unequivocally confirmed as a major risk factor for 
periodontitis. The risk is increased by roughly three times in diabetics when 
compared to non-diabetics. There has recently been much emphasis on the two way 
relationship between diabetes and periodontitis meaning not only is diabetes a risk 
factor for periodontitis but also periodontitis have negative effect on glycaemic 
control. The effect of periodontitis on diabetes mellitus is believed to result from the 
nature of the inflammatory response in the periodontal tissues.  
There are many theories which propose factors such as advanced glycation 
end products, changes in collagen statue, and altered immune function that causes 
impaired polymorphonuclear leukocyte function which may facilitate bacterial 
persistence in the tissue and the accumulation of advanced glycation end products, 
which results from prolonged and chronic hyperglycaemia and increased secretion 
of pro-inflammatory cytokines such as tumour necrosis factor- and prostaglandin 
E-2. The increase in collagenase activity together with the reduction in collagen 
synthesis will adversely influence collagen metabolism. This would result in 
compromised wound healing as well as periodontal tissue destruction.51 
Considering the fact that several oral health issues are linked to diabetes 
mellitus (as mentioned above) several studies have been conducted to identify such 
oral health complications as proposed and know to be affected by diabetes mellitus 
and also their impact on the quality of life . 
Review of Literature 

 
A study was conducted to compare the frequency and severity of Oral  
Candida colonization in 60 patients with insulin dependent diabetes mellitus(IDDM) 
admitted to a low intensity care diabetes unit with those in  age and sex matched 
controls by taking swabs from tongue and buccal mucosa. They concluded that in 
IDDM there is a predisposition to oral candidiasis and is independent of glucose 
control.52 
A study was conducted to find out the various oral manifestations in sample 
of 70 diabetic patients, divided into controlled and uncontrolled patients. Medical 
history and stomatological data were recorded and diabetic patients were matched to 
uncontrolled patients. The main symptoms that researchers observed were 
hyposalivation, taste alterations and burning mouth, with the main sign being parotid 
enlargement. The lesions observed were candidiasis of the erythematous type and 
proliferative lesions both associated to the use of total prosthesis. No pathognomic 
lesions or alterations could be observed in relation to the disease. The frequency of 
carriers of Candida albicans and also the lesions observed could be compared to 
normal patients also using total denture.53 
A study was done to investigate oral disorders and to compare the findings 
with the occurrence of neuropathy in type 2 diabetes mellitus. Mucosal diseases, 
tooth loss, and temporomandibular joint dysfunction were examined in 45 patients 
with long-term type 2 diabetes mellitus and in 77 control subjects. The occurrence of 
neuropathy was evaluated by neurophysiologic tests. Researchers concluded that 
diabetic neuropathy was found to be associated with tooth loss and 
temporomandibular joint dysfunction.48 
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A study with the aim of studying oral health in patients with type 2 diabetes 
was carried out in 102 randomly sampled diabetic patients and 102 age and gender 
matched non-diabetic subjects from the same geographical area. Oral conditions 
were examined clinically and radiographically. They found out that diabetic patients 
suffered from xerostomia to a significantly higher degree than non-diabetic controls 
did. Diabetic subjects also showed a greater requirement of periodontal treatment, 
caries prevention and prosthetic rehabilitation. Patients with longer duration of 
diabetes had more manifest caries lesions as had those on insulin treatment when 
compared with patients on oral/diet or combined treatment. They concluded that 
individuals with type 2 diabetes in some oral conditions exhibited poorer health.54 
A study was conducted to determine the prevalence and characteristics of 
oral soft tissue diseases identified during a comprehensive oral evaluation of 405 
adult subjects with diabetes and 268 control subjects without diabetes. Subjects with 
diabetes had significantly higher prevalence for fissured tongue, irritation fibroma, 
and traumatic ulcers. They also found out that there were no differences found 
between the subjects with diabetes and the control subjects for lichen planus, 
gingival hyperplasia, or salivary gland disease. Hence  they concluded that oral soft 
tissue lesions were seen more frequently in subjects with insulin-dependent diabetes 
than in the control subjects.41                                                     
A study  was conducted to compare the prevalence of candidiasis in 405 
subjects with IDDM and 268 non diabetic control subjects. Subjects with IDDM 
were found to have clinical manifestations of candidiasis, including median 
rhomboid glossitis, denture stomatitis, and angular cheilitis. They also found out that 
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use of antimicrobials, immunosuppressants, or drugs with xerostomic side effects 
was not related to the presence of Candida. Study concluded that the presence of 
Candida pseudohyphae was significantly associated with cigarette smoking, use of 
dentures, and poor glycemic control.42 
A study was conducted to explore the effect of periodontal therapy on 
glycemic control in 36 persons with type 2 diabetes mellitus (DM) who received 
therapy for adult periodontitis during an 18-month period. Another 36-person 
control group was randomly selected from the same population of persons with type 
2 DM and did not receive periodontal treatment.. During the nine-month observation 
period, there was a improvement in glycemic control in the treatment group and it 
was concluded that periodontal therapy was associated with improved glycemic 
control in persons with type 2 DM.55 
 A study was conducted  to assess  the prevalence of DM in 62 OLP patients 
and also to investigate the existence of clinical and pathological differences between 
OLP patients with or without DM. The variables studied for each patient were age, 
sex, clinical presentation, extension of the lesions, location of the lesions, number of 
locations, Candida albicans colonization, and density of subepithelial inflammatory 
infiltrate. Researchers concluded that  OLP cases were associated to type 2 DM and 
also were related to an impaired fasting glucose (IFG). No significant differences 
could be observed in terms of clinical and pathological features between diabetic 
and non-diabetic OLP patients.56 
A stomato-oncological study was carried out on 200 diabetic patients  and 
the control group included 280 adults. The lesions found were classified into three 
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groups: inflammatory lesions, benign tumors, and precancerous lesions. A 
retrospective diabetes screening of 610 inpatients with histologically confirmed oral 
malignancies was also performed. The control group comprised 574 complaint- and 
tumor-free adults. Fasting blood glucose levels were determined in both groups, and 
the tumor location was registered in the cancer patients. Researchers found benign 
tumors  in 14.5% and precancerous lesions in 8% of diabetic patients. In the control 
group these values were significantly lower. The proportion of oral cavity lesions 
was higher among diabetic patients compared with that of the control patients. In the 
oral cancer patient group, diabetes was present in 14.6% and an elevated blood 
glucose level in 9.7%. These values are significantly higher than those for the 
tumor-free control group. The gingival and labial tumor location was significantly 
more frequent among diabetic cancer patients than in the nondiabetic group .The 
combination of diabetes and smoking means a higher risk for oral precancerous 
lesions and malignancies.It was concluded that diabetes may be a risk factor for oral 
premalignancies and tumors.57 
A study was conducted to investigate the effect of improved periodontal 
health on metabolic control in type 2 diabetes mellitus (DM) patients. Fourty-four 
patients with type 2 DM were selected. Subjects were randomly assigned into two 
groups.Plaque index (PI), gingival index (GI), probing pocket depth (PPD), clinical 
attachment levels (CALs), gingival recession (GR) and bleeding on probing (BOP) 
were recorded at baseline at 1st and 3rd months.Fasting plasma glucose (FPG), 
2hours post-prandial glucose (PPG), glycated haemoglobin (HbA1c), total 
cholesterol (TC), triglyceride (TG), HDL-cholesterol, LDL-cholesterol and micro 
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albumin were analysed at baseline, 3 months following the periodontal therapy. The 
treatment group received full-mouth scaling and root planing whereas the control 
group received no periodontal treatment. A statistically significant effect could be 
demonstrated for PI, GI, PPD, CAL and BOP for the treatment group. HbA1c levels 
in the treatment group decreased significantly whereas the control group showed a 
slight but insignificant increase for this parameter.Hence it was concluded that non-
surgical periodontal treatment is associated with improved glycaemic control in type 
2 patients and could be undertaken along with the standard measures for the diabetic 
patient care.58 
A study was conducted to assess oral signs, symptoms and oral lesions its  
type and prevalence, in diabetic patients with end stage renal disease(ESRD). A total 
of 229 individuals were examined .They were divided into two groups ESRD DM 
on dialysis, and non-ESRD DM . Known DM evolution time, dialysis treatment type 
and duration, and laboratory results were recorded. An oral exam was performed, 
searching for signs, symptoms and ESRD-associated oral lesions. Signs and 
symptoms which are of higher prevalence  in DM patients with ESRD  on dialysis  
are uremic breath, unpleasant taste  and xerostomia  being the most frequent ones. 
The most frequent OL were dry, fissured lips , saburral tongue  and candidiasis . No 
difference was found in candidiasis prevalence between groups. Candidiasis was 
found associated to xerostomia  and smooth tongue only in group of patient on 
dialysis .Researchers concluded that  ESRD DM patients had a significantly higher 
prevalence of signs, symptoms and OLs, as compared to non-ESRD DM patients.59  
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A study consisting of 371 adult T1DM subjects and 261 control subjects was 
carried out to assess the prevalence and predictor factors of burning mouth 
syndrome BMS. BMS or related discomforts occurred slightly more frequently in  
T1DM patients than in the control group. Symptomatic T1DM subjects were more 
likely to be female who had also developed peripheral neuropathy. These findings 
and other similarities between BMS and diabetic peripheral neuropathy suggests  
that a neuropathic process may be an underlying source of BMS in some patients 
who have no apparent oral abnormality.60 
A study was conducted to evaluate the prevalence of superficial lesions in 
the oral cavity mucosa in diabetic patients. 30 diabetes mellitus patients were 
selected .Thirteen different types of mucosal alterations were diagnosed. Tongue 
varicose veins and candidiasis were the most prevalent. Such alterations can be 
associated with the fact that these conditions are commonly found in senile  patients  
and  are also associated with prolonged wear of dentures. Xerostomia was diagnosed 
in only 3.33% patient, disagreeing with most of the studies observed in the literature. 
They have concluded that most of the diabetic patients presented at least one type of 
oral mucosa lesion or alteration.61      
A study was done to compare diabetic and non diabetic subjects wearing 
complete dentures with regard to salivary flow, salivary buffering capacity, denture 
retention, and oral mucosal lesions in sixty subjects, 30 with and 30 without a 
diagnosis of diabetes, were matched for gender, race, and age. Salivary flow, 
salivary buffering capacity, glycemia, blood pressure, presence of mucosal lesions, 
denture retention, use of medications, and behavioural factors (controlled or 
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uncontrolled diet, alcohol consumption, and smoking) reported by the subjects, were 
evaluated. It was concluded that no significant differences were observed in salivary 
flow, denture retention, or oral lesions in diabetic and nondiabetic subjects.62 
A study was done to investigate the prevalence of xerostomia (feeling of 
mouth dryness), hyposalivation (the reduction of saliva), and oral microbiota in Thai 
patients with type 2 DM. One hundred and fifty-four ambulatory patients with type 2 
DM and 50 non-diabetic control subjects were interviewed for symptoms of 
xerostomia. The medical records of these subjects were reviewed for pertinent 
medical history and laboratory investigations regarding their diabetic control. Oral 
examination and measurement of hyposalivation using a modified Schirmer test 
(MST) were performed. The presence of oral microbial flora was investigated using 
a modified dip-slide test. Results: The prevalence of xerostomia was found to be 
62% in patients with type 2 DM compared with 36% in the nondiabetic control 
group. The prevalence of hyposalivation was 46% in the patient group, whereas only 
28% of the control group had hyposalivation. Patients with hyposalivation had 
significantly higher numbers of mutans streptococci, lactobacillus spp., and candida 
spp. in the saliva compared with those without hyposalivation. It was concluded that 
xerostomia and hyposalivation were prevalent in patients with type 2 DM and were 
associated with higher numbers of oral pathogens in the saliva.63   
  A study was done to evaluate the prospective associations between type 2 
diabetes mellitus (T2DM) and the risk of periodontitis and tooth losswhere 
researchers examined 35,247 male participants were followed from 1986 to 2006. 
Data on self-reported diabetes, periodontitis, tooth loss and potential confounders 
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were collected at baseline and biennially through mailed questionnaires. Results 
showed that men with T2DM has increased risk of periodontitis compared to those 
without, when adjusted for age, race, smoking, BMI, fruit and vegetable intake, 
physical activity, alcohol consumption and dental profession. It was concluded that 
type 2 diabetes mellitus was associated with a significantly greater risk of self-
reported periodontitis.64 
A study was done to investigate  the oral manifestations in type 2 diabetes 
mellitus (DM) and to establish an association between oral manifestations and 
associated microvascular and macrovascular complications. 50 cases of DM were 
selected who had oral complications. The control group comprised 50 age- and sex-
matched diabetic patients without any oral complications. It was found that oral 
manifestations in DM included periodontal disease in 34%, oral candidiasis in 24%, 
tooth loss in 24%, oral mucosal ulcers in 22%, taste impairment in 20%, xerostomia 
and salivary gland hypofunction in 14%, dental caries in 24%, and burning mouth 
sensation in 10% cases. Fasting and postprandial blood glucose levels were 
significantly higher among cases. Neuropathy, retinopathy, nephropathy, 
cardiovascular disease, dyslipidemia, and sepsis were  which were found to be 
significant too. It was concluded that several oral complications are seen among 
diabetics and association of oral markers in DM and microvascular complications 
suggests that there is a significant association between the two.65 
A study was conducted to compare the clinical and subjective oral health 
indicators of type 2 diabetic patients (154 diabetes and 303 healthy subjects) with age 
and gender matched non diabetic controls as well as to identify clinical and subjective 
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oral health indicators that discriminate between well controlled and poorly controlled 
type 2 diabetes mellitus patients as well as between patients with long and short term 
duration. The results showed that chronic periodontitis,tooth mobility, furcation 
involvement and oral impacts on daily performance were more prevalent among type 
2 diabetes patients when compared to their non diabetic controls.66 
A study was conducted in 51 diabetes patients to determine the prevalence of 
oral mucosal lesions in patients with diabetes mellitus (both type 1 and type 2 
included). The  result of the study shows a high prevalence of oral mucosal lesions 
in diabetes patients. Lesions are mostly associated with diabetes type 2 and lip and 
tongue were most common locations.67 
A study was carried out in 395 type 2 diabetes patients and 405 healthy 
individuals to explore association between oral mucosal alterations and type 2 
diabetes mellitus. The result showed that the prevalence of oral mucosal lesions was 
higher in type 2 diabetic than non diabetics and also provides evidence that diabetes 
has a negative influence on oral health. They also did not find any association 
between type 2 diabetes mellitus and potentially malignant disorders.68 
A study was conducted  by comparing 60 diabetic patients with 60 healthy 
subjects for evaluating various oral health complications associated with Diabetes 
Mellitus. The results showed that periodontitis followed by hyposalivation, taste 
dysfunction, halitosis, lichen planus were the common manifestations. It was 
concluded that oral manifestations in uncontrolled diabetes are more severe and 
intense monitoring of prevention as well as early treatment is necessary in both 
controlled and uncontrolled diabetes.69 
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MANAGEMENT OF ORAL HEALTH COMPLICATIONS 
Xerostomia  
Main objective in management of dryness of oral cavity is  to encourage 
salivary stimulation to keep the mouth moist, prevent caries and candida 
infection.The use of saliva substitutes and stimulants is recommended. Patient can 
also be encouraged to chew sugarless gum to stimulate saliva production.12 
Candidiasis
Topical and systemic agents are available for treatment of oral candidiasis. 
Clotrimazole troches are available and is given as 10mg troche 4 times/day for 2 
weeks. Systemic medications  commonly used are: Fluconazole 100mg/day for 2 
weeks Ketaconazole 200mg/day for 2 weeks Itraconazole 200mg/day for 2 
weeks.12  
Burning Mouth Disorder 
Commonly associated with dryness  and  candidal infection , management 
includes treatment of these conditions along with improved glycemic control. 
Symptoms of burning mouth have been found in undiagnosed cases of Type 2 
diabetes, most of which have been resolved after medical diagnosis and subsequent 
treatment, directed at improving glycaemic control. Benzodiazepines, tricyclic anti 
depressants and anti convulsants can be given in low doses to relieve the symptoms 
of burning mouth syndrome.12 
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Gingivitis and Periodontitis 
The principle behind treatment of gingivitis is to reduce inflammation by 
eliminating plaque and calculus through scaling and polishing as untreated gingivitis 
progress to periodontitis. The use of a mouthwash is also recommended. Although 
there are many mouthwashes available, the efficacy of chlorhexidine has been 
shown to be very good. This drug has been shown to be the most effective 
antiplaque and antigingivitis chemotherapeutic agent available. 
Periodontal treatment is an essential requirement in a diabetic patient.12 The 
therapeutic goal in periodontal disease is to alter or eliminate the origin of the 
microbes and all contributing factors so as to prevent disease progression and to 
prevent recurrent periodontitis .  Patients with diabetes should receive regular 
scaling so as to remove plaque and calculus deposits. Oral hygiene practices like 
brushing 2 times/day and flossing should be reinforced by the dentist. 
The use of antibiotics is recommended and drugs  often  used are: 
Amoxicillin 500mg three times a day for 5 days for patients who are not allergic to 
penicillin Erythromycin 500mg three times a day for 5 days for patients who are 
allergic to penicillin. Each of the above-mentioned drugs must be accompanied by 
any of the following: Metronidazole 400mg  three times a day for 5 days or 
Clindamycin 600mg three times a day for 5 days or Clavulanic acid and Amoxicillin 
625mg two times a day for 5 days. These drugs target a broad spectrum of bacteria 
which is why they are used for periodontitis management.16 
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Periodontal surgical procedures are performed on patients with advanced 
periodontitis. Surgical treatment of periodontitis involves removal of inflamed 
tissues to reduce the damage to the alveolar bone around the infected area and this 
has an added advantage since it enhances accessibility to areas where root planning 
and scaling could not be reached to remove plaque and calculus.16 
 Dental caries 
Dental caries is treated according to the severity of the lesion. If left 
untreated the caries will progress and eventually lead to tooth loss. It is important to 
remember the association of caries with hyposalivation since they may well be the 
contributing factor to dental caries in a diabetic. Caries is a process. In its early 
stages, tooth decay can be stopped. Topical treatments such as fluoride-containing 
mouth rinses and fluoride compounds, gels, aqueous solutions and dentrifices can 
prevent occurrence as well treat initial caries.70 Dentists should also reinforce  oral 
hygiene practices and dietary counselling to the patient so that the patient can brush, 
floss and choose less cariogenic foods, all of which will enhance caries prevention.  
Once a lesion has cavitated, especially if dentin is involved, remineralization 
is much more difficult and a dental restoration is usually indicated operative 
treatment. Restorative materials include dental amalgam, composite resin, porcelain. 
In certain cases, endodontic therapy may be necessary for the restoration of a tooth. 
Endodontic therapy, also known as a root canal treatment, is recommended if the 
pulp in a tooth dies from infection by decay-causing bacteria or from trauma. During 
a root canal, the pulp of the tooth, including the nerve and vascular tissues, is 
removed along with decayed portions of the tooth. The canals are instrumented with 
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endodontic files to clean and shape them, and they are then usually filled with a 
rubber-like material called gutta percha. The tooth is filled and a crown can be 
placed. An extraction can also serve as treatment for dental caries. The removal of 
the decayed tooth is performed if the tooth is too far destroyed from the decay 
process to effectively restore the tooth. 
Altered taste sensation 
This condition has a strong correlation for Candida and hyposalivation, a 
positive outcome is achieved by treating the accompanying fungal infection. 
Improvements in altered taste sensation may occur when metabolic control  is 
established or when hyposalivation and associated candidiasis are controlled.17 
Management of emergencies in diabetic patients in Dental surgery 
Dentists should be well aware about  hypoglycaemia, a condition that is 
highly dangerous as it may lead to the patient loosing consciousness. The classical 
signs and symptoms of hypoglycaemia include sweating, tremors, confusion, 
agitation, anxiety, dizziness, tingling or numbness and tachycardia. If this condition 
is suspected it can be confirmed by taking a glucometer reading and the patient must 
be given 15g of glucose orally. In the event that a patient is unable to take this 
glucose orally, an intravenous line  should be set up and 25-50ml of 50% dextrose 
solution should be administered.15  A subcutaneous injection of 1mg of glucagon 
should be injected in case it is not possible to set up the IV line. After the treatment, 
the signs and symptoms of hypoglycaemia should resolve between 10-15 minutes. 
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As a precaution, the patient must be observed for 30-60 minutes after recovery and 
the blood glucose levels can then be rechecked using the glucometer . 
It is not uncommon for marked hyperglycaemia patients to present with the 
exact symptoms as described for hypoglycaemia. Again, the important step is to 
confirm the glucose level with a glucometer. However, should a glucometer not be 
available it is safer to treat this as hypoglycaemia because the extra dose of glucose 
given will not have a significant or detrimental effect on the hyperglycaemia, but if 
the patient was not treated as hypoglycaemia, he could suffer life threatening 
outcomes.14 
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SOURCE OF DATA
This study was carried out in the Department of Oral Medicine and 
Radiology, Sree Mookambika Institute of Dental Sciences, Kulasekaram, 
KanyaKumari district, Tamil Nadu. 
METHOD OF SELECTION OF DATA 
1. Sample Size  
• Total number of subjects :254 
• Total no of diabetics : 127 
• Total no of non diabetics: 127 
2. Selection of Cases 
. Inclusion criteria:
• Being diagnosed with Type 2 Diabetes Mellitus for more than 1 year 
and attending a diabetic clinic. 
• With Fasting and Post Prandial Blood sugar values 
Exclusion criteria:   
• patients not willing for study 
• smoking and tobacco chewing 
• type 1 diabetes 
• other systemic complications like hypertension, thyroid disorders etc. 
•  pregnancy 
•  current acute illness  
•  professional periodontal treatment received during last 6 months 
•  antibiotics , steroidal medication used during last 3 weeks. 
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3. Selection of Control Group 
 Control group : age, gender matched non diabetic healthy individuals 
visting our college for other treatment 
PARAMETERS TO BE STUDIED :
a) Dental  status   
b) Periodontal status 
c) Xerostomia/ dryness of oral cavity 
d) Oral burning/  oral dysesthesia 
e)  Dysgeusia 
f)         Candidiasis 
g) Non candidal/ other mucosal lesions 
h) Sialadenitis/ salivary gland enlargement
MATERIALS REQUIRED 
 Kidney Tray 
 Mouth mirror 
  Straight Probe 
 Explorer
 Mouth Mask 
 Diagnostic Gloves 
 Gauze pad and Cotton roll
 Wooden spatula/ Ice cream stick 
 Glass slides 
 CPITN probe 
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 Fixative spray 
 BP Handle ,  no 15 blade , needle holder, sutures 
 10% Formalin solution 
  Calibrated beaker and  sugar free chewing gum 
 PROCEDURE IN DETAIL  
Complete study is explained to the patients and healthy volunteers  and 
written consent is  taken in a prefilled form. The study comprises of two stages : 
Stage one involves data collection through questionnaire and recording 
fasting and post prandial blood sugar values of each patient visiting the department. 
Stage two involves detailed intraoral examination and recording the details in 
questionnaire followed by necessary  investigation.
Dental status of  all patients is assessed by DMFT (decayed, missing, filled ) 
index followed by periodontal status is assessed using CPITN (Community 
Periodontal Index of Treatment Needs) index.71 
Dryness of oral cavity or hyposalivation is diagnosed by asking the patient to 
chew on sugar free gum base for 5 minutes without swallowing  (roughly 45 strokes 
per minute) and spit into calibrated cup after 5 mins.
Burning mouth sensation is assessed using DN4 questionnaire (Douleur 
Neuropathique en 4 questions).72 
Candidiasis is assessed by  scraping with moistened ice cream stick from the 
posterior aspect of dorsum of tongue of the patient and is smeared over a glass slide 
and sprayed with commercially prepared fixative. The slides are coded and 
submitted to Department of Oral Pathology for identification of candidal hyphae. 
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Bilateral enlargement  of the parotid salivary glands if observed is noted. 
Ulceration if noticed is examined for size, shape, location and is noted. 
Patient is also questioned about altered taste using NCI (National Cancer Institute) 
grading.
Any other mucosal observations (swelling, growth) are also recorded after 
detailed intraoral examination of each patient. Biopsy is taken whenever detailed 
investigation is required. Tissue is placed in 10% formalin and send for 
histopathological examination to  Department of Oral Pathology.  
All patient data are recorded in a case record form. 
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The present study was undertaken to find out common oral health 
complications in Type 2 Diabetes Mellitus patients  in Kanyakumari District, 
followed by  comparison of oral health status between diabetic and non diabetic 
patients as well severity in stomatological changes observed between controlled and 
uncontrolled diabetics. 
Statistical analysis: 
The data was analysed by Statistical Package for Social Sciences (SPSS 
16.0). Chi square test was applied to find the statistical significance between the 
groups. P value less than 0.05 (p<0.05) considered statistically significant at 95% 
confidence interval. 
Results show comparison of various oral manifestations observed in 
diabetics and nondiabetics. Comparison was also done in controlled group and 
uncontrolled group. Table 2 and graph 1 shows distribution of patients according to 
status of diabetes. Graph 2 shows distribution ofpatients according to gender. Graph 
3 shows bar diagram based on medication. Table 3 and Table 4 shows distribution of 
patients based on various non candidal lesions observed in diabetic and non 
diabetics and also in controlled and uncontrolled diabetic patients. Table 5,6,7,8,9, 
10, 11, 12 and graphs 4.5,6,7,8,9,10 shows distribution of patients according to 
salivary gland enlargement, burning sensation of oral cavity, candidiasis, halitosis, 
dysgeusia and periodontitis respectively. 
Only ulcerative lesions, angular chelitis, pigmentation, geographic tongue 
was found to be significant (p value <0.05). Fissured tongue, lichen planus/ 
lichenoid reactions as well as fibroma/polyp though observed were insignificant.
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The more frequent manifestation observed in diabetic patient was 
periodontitis (79%) followed by oral candidiasis (78.69%), oral burning sensation 
and altered taste (73.42%) and hyposalivation (67.39%). Most common mucosal 
disorders observed is geographic tongue (24%) followed by hyperpigmentation 
(21%). 
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Great physician Sir William Osler quoted  “Mouth is the mirror to the body”. 
I would like to go one step further and state that mouth mirrors what body wants to 
show.
Oral  physicians  can  play  a  pivotal  role  in  diagnosing  the undiagnosed 
cases of this most common and debilitating endocrine disease on the basis of the oral 
signs and symptoms. The study of oral health abnormalities in diabetic patient is 
important due to need of greater knowledge as well conflicting results in regards to 
the prevalence of  oral abnormalities in literature as well as the fact that diabetes is a 
world wide health problem. 
          The present study was undertaken to determine the oral health status in type 2 
diabetes mellitus patients and also to compare the variations in the stomatological 
changes in controlled and uncontrolled diabetes. This  study was conducted in the 
Department Of Oral Medicine and Radiology, Sree Mookambika Institute of  Dental 
Sciences, Kulasekaram, KanyaKumari district, Tamil Nadu. The total sample size 
was 254. This included 2 groups, 127 type 2 DM patients and 127 healthy 
individuals. Samples were selected based on our preformatted inclusion and 
exclusion criteria. 
Out of 127 diabetic cases examined 114 patients were under allopathic 
system of medication while 13 patient were either not under medication or following 
diet control or alternative medications. 67 patients had uncontrolled diabetes based 
on fasting and post prandial blood sugar value. 54 of the patients were females. In 
this study oral health complications was significantly higher in diabetics .These 
disorder are also assossiated with increased glycemic values. 
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In this study the most important health complication noticed in both 
controlled and uncontrolled diabetics was Periodontitis. The prevalence of   
periodontal disease was found to be 79% .It was found that uncontrolled  and long 
duration diabetic patients presented  with severe manifestations of periodontitis like 
recession, furcation involvement ,mobility and pus exudation from periodontal 
pockets  when compared to their controlled diabetic counterparts. The present study 
is consistent with study by Brian et al among 2273 diabetics, the prevalence of 
periodontal disease was high , incidence of which being 2-6 fold higher.73 A study 
was done by Tsai et al74 in which it was proved that patients with poorly controlled 
diabetes had a significantly higher prevalence of severe periodontitis when 
compared to those without diabetes. The level of glycaemic control is of key 
importance in determining increased risk. Maike et al75 from his study suggested 
that incidence and severity of periodontitis are influenced by presence or absence of 
DM as well as severity of hyperglycemia. Improving glycemic control is likely to 
reduce risk and severity of periodontitis. Periodontal therapy in diabetics showed 
marked improvement in glycemic control which is clinically significant in 
management of diabetes. 
          The next most common disorder observed in our study was oral candidiasis 
and its prevalence was nearly 78%  of which uncontrolled diabetics were found to 
have  increased prevalence when compared to controlled diabetics. The most 
common symptom  patients complained was burning sensation but some of them 
were asymptomatic too. Lamster et al22 indicated that the presence of candidiasis is a 
common manifestation of immuno compromised state.                       
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A study done in edentulous type 2 diabetics by Bobkowska and 
Ziolkiewicz76  has shown that nearly 57 % had  denture stomatitis which is a form of 
candidiasis when compared to control group. Another study done by Bartholomew 
and Rodu77 in insulin dependent diabetes patients  states  that there is predisposition 
to oral candidiasis and is independent of glycemic control. But the studies done by 
Knight and Fletcher 78 states that increased salivary glucose levels promote overall 
growth of candida in diabetics. The  results of  our study is consistent with this 
observation in the sense that the number of  patients  affected  by candidiasis is 
higher in diabetics. Angular chelitis (fissuring of the corners of mouth) was noticed 
in 10% of diabetic population examined which also represents a form of candidiasis  
.This condition is of higher prevalence in diabetics than non diabetics as were in our 
study also. Guggenheimer et al 42 also reported a high prevalence of angular cheilitis 
associated with the presence of Candida. 
Next observed oral health complications in our study were altered taste and 
oral burning sensation which were prevalent among 73% of diabetic patients 
examined. Taste alteration was observed by most of the diabetic patients but they 
were not aware that condition is a complication of long standing diabetes  and 
medication. Taste alteration is more common in uncontrolled diabetics and in our 
study  taste alteration was noticed in 67% in uncontrolled diabetics. Altered taste 
sensation was noticed in the studies conducted by Sidharta et al79  which back up our 
study results.  
  Oral  Dysesthesia/burning mouth sensation was reported by 73% of diabetic 
population examined by us. This is a common symptom in diabetic patients that we 
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examined. Collin et al 48 states that the burning sensations in diabetics are frequently 
accompanied by changes in taste or other sensory distortions. In our study oral 
mucosal disorders like candidiasis, lichen planus,dryness of oral cavity also 
contributed oral burning sensations. 
The relationship between dental caries and diabetes is complex.                     
Even though it is stated in literature that patients with diabetes are susceptible to oral 
infection that leads to tooth decay and loss, our study shows that prevalence of 
decay and tooth loss is almost equal in both diabetics and non diabetics. Slight 
increase in prevalence of DMFT scores was observed in uncontrolled DM when 
compared to controlled DM. Ship32 has stated in his review that he was not able to 
find any specific association of occurrence of dental caries in diabetic patient which 
is quite contradictory.
Dryness of oral cavity/hyposalivation was observed in 63% of diabetic 
population when compared to non diabetics and also its prevalence is increased in 
uncontrolled diabetics  (52%) than controlled patients  (48%). Flow rates have been 
reported to be significantly lower in patients with poorly controlled diabetes as 
reported by Sreebny LM39 and Chavez38 which is consistent with our studies. Half of 
the diabetics examined felt that they had dry mouth while one third of the patients 
felt need to drink water to swallow dry food item while 10 patients reported that 
they find difficulty in speaking  due sticking of tongue to palate .According to 
Vernillo 12  the etiology for dryness experienced by patients could be due to diabetic 
neuropathy, medication, structural changes in salivary gland , polyuria, dehydration 
due to hyperglycemia.  Shrimali et al 80  has conducted a study in which she states 
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that  hyposalivation , halitosis and periodontitis are most common manifestations  
observed which were also noticed in our study. 
Halitosis was also noted in the study population though it was not a 
parameter in our study.  About 21% of diabetic population examined had halitosis, 
majority of them fell into uncontrolled  group. It is primarily caused by bacterial 
putrefactions and generation of volatile sulphur compound. 
Benign salivary gland enlargement ( parotid gland) was observed in 8% of 
diabetic cases examined in the study. Russotto et al reported in  24 % of the total 
number of 200 patients with overt or latent diabetes, were found to have bilateral 
asymptomatic enlargement of the parotid glands. This is consistent with our results . 
Bilateral  enlargement  of parotid salivary gland was also reported by  Lalla and 
Manfredi81  in uncontrolled diabetes patients . 
This study identified a high prevalence of oral mucosal lesions (non candidal 
lesions) among patients with diabetes mellitus when compared with control group. 
The lesions commonly noticed in Kanyakumari population were traumatic ulcers, 
apthous ulcers, angular chelitis, pigmentation, geographic tongue, fibroma/ polyp, 
fissured tongue, lichen planus/ lichenoid reaction. Due to the high prevalence  of  
these  lesions  in  the  population,  oral physicians  should be aware of the clinical 
appearance, etiology, diagnosis and the required treatment for the lesion. 
The  prevalent mucosal lesion recorded was geographic tongue (24.14%) and 
it is of almost equal distribution among non diabetic individuals (22.83%) also. But 
it was also observed  in our study that people in Kanyakumari district has higher 
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incidence of geographic tongue but  due  to  the  lack  of  similar studies in South 
Indian population, no conclusion can be drawn regarding the exact prevalence in this 
region. Most of the patients were asymptomatic and reported to the our clinic with 
other dental problems. Very few patients were aware of the lesions. Males were 
more frequently to be affected than females in our study. Male predominance has 
been reported by Vörös-Balog et al.82
The next most common lesion observed was pigmentation of oral mucosa 
(21.25%) in study population. In non diabetic it was observed to be 22%.Almost 
equal prevalence was observed between diabetics and non diabetics. Presence of 
increased melanin pigmentation in diabetes patients  was observed by Silva et al67
and it was found to be 13.7%. Difference (increase in our study) was due to 
pigmentation of racial origin which is commonly observed  in South Indian 
population.
This study identified prevalence of ulcerative lesion to be 18% of which 
apthous ulceration is 12.59% and traumatic ulceration is 5.5% among diabetic 
population examined. In studies conducted by Silva et al67 and  Bajaj .S65, they also 
have found increased prevalence of ulcerative lesions in type 2 diabetic population. 
Another common mucosal lesion found in diabetic population is angular 
chelitis which is of 9.4% prevalence when compared to non diabetics which 3.14%. 
This correlates to study results observed by Silva et al.67 It has equal prevalence 
among both controlled and uncontrolled diabetics. Presence of  actinic chelitis is an 
important observation because of its malignant potential. 
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Fissured tongue was also observed in our study and its prevalence rate was 
found to be 7% in diabetics and 3.14% in non diabetics. It is almost equally noticed 
in controlled and uncontrolled diabetics. Presence of fissured tongue was also 
noticed in the study done by Silva et al.67
Other oral manifestation observed lichen planus , lichenoid reaction,fibroma, 
polyp , lingual varicosities , fordyces granules were also noted in diabetic population
but are statistically insignificant in our study. Most of the diabetic patients presented 
at least one type of oral mucosal lesion or alteration. Uncontrolled diabetic patients 
showed more oral manifestations than controlled patients, although none of them 
was a pathognomonic lesion. 
The present study helped to familiarise the common stomatological 
manifestations noticed in type 2 diabetes mellitus patients and also possible 
complication in both controlled and uncontrolled group of diabetics.  And also 
results emphasize the importance of oral physicians monitoring the oral health of 
patients with diabetes mellitus and also patients should  be encouraged to consult 
oral health care providers on a regular basis .
Conclusion and Summary 
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Diabetes affects people of all ages and its prevalence is rapidly increasing. 
Systemic complications of diabetes mellitus were found to be significantly 
predominant among patients with oral health complications and increases the 
importance of the present study.  
The  present study was undertaken to find out common oral health 
complications in Type 2  Diabetes Mellitus patients, followed by  comparison of oral 
health status between diabetic and non diabetic population as well severity in 
stomatological changes observed between controlled and uncontrolled diabetics. 
This cross sectional study was conducted in diabetic individuals and age gender 
matched non diabetic healthy volunteers.  
The study was undertaken because the oral cavity exhibits the first sign of an 
undiagnosed or uncontrolled diabetes, hence oral health care providers must be well 
aware of signs and symptoms to refer them to a physician for further investigation as 
well as manage and treat the oral health complications. Conditions like periodontitis 
(mobility of teeth, presence of plaque and calculus, periodontal abscess, gingititis, 
recession, extensive bone loss), candidiasis, xerostomia though not exclusive for 
diabetics can result from uncontrolled hyperglycemia. 
Significant observations were made and also it was noticed that most of the 
patients exhibited alteast one oral health complication. The study helped to 
familiarise the common stomatological manifestations noticed in type 2 diabetes 
mellitus patients and also possible complication in both controlled and uncontrolled 
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group of diabetics. It was observed that diabetic individuals had more  oral health 
complications than non diabetic persons.
Knowledge of oral comorbidity among people with diabetes is generally 
poor which could be clearly recognised from our study and also it requires oral 
health care providers to give appropriate health education to improve oral health 
status of diabetic population. Hence patients should be encouraged to consult oral 
physicians on a regular basis to ensure the heath of their oral cavity. The study also 
draws attention to promote oral health strategies at community level at large to help 
people to understand the relationship that exhibits between diabetes and oral health 
as there lack of awareness or oral cavity problems among common people. 
 The oral cavity exhibits the first sign of an undiagnosed or uncontrolled 
diabetes, hence oral health care providers must be well aware of signs and symptoms 
to  refer them to a physician for further investigation as well as manage and treat the  
oral health complications. There is also evidence indicating that poor oral health can 
affect glycemic control hence effective health care partnerships between oral 
physicians, general physicians and dieticians is the ideal scenario for optimal disease 
management. Oral health providers can plays an important role by identifying and 
treating oral diseases, by encouraging the diabetic individual to maintain rigorous 
oral hygiene and follow proper diet. 
There is need for future longitudinal studies among diabetic patients to elicit 
accurate knowledge regarding the development and progression of oral diseases as 
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well results of interventional procedures and treatment (both medical and dental) 
instituted in the patients and its correlation with their glycemic status. 
We conclude our study by stating that oral physicians can play pivotal role to 
identify, treat various oral health problems, encourage patient to receive routine 
stomatological care thereby we can enhance the quality of life for patients with Type 
2 Diabetes Mellitus. 
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Professor and Head 
                     Department of Oral Medicine and Radiology 
              Sree Mookambika Institute of Dental Sciences 
                 Kulasekharam, KanyaKumari District-629161  
3. Name of the Co-Guide:    Dr Shashi Kiran M MDS 
       Reader 
                   Department of Oral Medicine and Radiology. 
                                                  Sree Mookambika Institute of Dental Sciences. 
     Kulasekharam, KanyaKumari District-629161  
4. Institute:   Sree Mookambika Institute of Dental Sciences,
      V.P.M Hospital complex, Padanilam,  
      Kulasekharam, 
      Kanyakumari – 629161, Tamilnadu 
5. Title of the study: Prevalence of Oral Health Complications in Type 
II Diabetes mellitus patients : A Descriptive study
Dear Volunteers,
We welcome you and thank you for your keen interest in 
participation in this research project. Before you participate in this study, it is 
important for you to understand why this research is being carried out. This 
form will provide you all the relevant details of this research. It will explain the 
nature, the purpose, the benefits, the risks, the discomforts, the precautions and 
the information about how this project will be carried out. It is important that 
you read and understand the contents of the form carefully. This form may 
contain certain scientific terms and hence, if you have have any doubts or if you 
want more information, you are free to ask the study personnel or the contact 
person mentioned below before you give your consent and also at any time 
during the entire course of the project. 
6. Background information: 
         Diabetes mellitus is a metabolic syndrome considered to be caused by multiple 
factors resulting   from deficiency of insulin, which may be absolute due to 
pancreatic beta cell destruction or relative  due to increased resistance of the 
tissue to insulin. Diabetes mellitus (DM) is a major public health concern 
worldwide. The number of diabetic individuals is increasing because of 
population growth, aging, increasing prevalence of obesity and urbanization. It 
has been reported that the number of DM individuals worldwide will rise from 
171 million (in 2000) to 366 million  by 2030.
7. Aims and Objectives:
 To identify and understand oral health problems of a type 2 diabetes mellitus 
patient visiting a dental college in Kanya Kumari District.   
 To determine frequency of various oral health complications in diabetes 
mellitus patients 
8. Scientific justification of the study:
            Diabetes Mellitus is a pernicious chronic disorder of the 
carbohydrate, fat and protein metabolism which is regarded as a true metabolic 
disorder as its effects are far-reaching, leading to pathological changes in every 
tissue of the body. It is critical therefore that oral health workers have a clear 
understanding of the disease in terms of its diagnosis, prevention and treatment 
so as to improve the quality of care offered to such patients. 
9. Procedure for the study:
  The study comprises of two stages: 
           Stage one involves data collection through a questionnaire about 
overall health status as well as oral health status. 
           Stage two involves intraoral examination and detailed investigations if 
required will be performed by principal investigator in Out Patient Department.
10. Expected risks for the participants: 
     NIL 
11. Expected benefits of research for the participants: 
   You will get a better knowledge about your oral health condition and 
various treatment and preventive options available to improve your oral health. 
12. Maintenance of confidentiality:
a. You have the right to confidentiality regarding the privacy of your 
medical information (Personal details, results of physical examinations, 
investigations, and  your medical history). 
b. By signing this document, you will be allowing the research team 
investigators, other study Personnel, sponsors, institutional ethics committee 
and any person or agency required by law to view your data, if required.  
c. The results of study performed as part of this research may be included in 
your medical record.  
d. The information from this study, if published in scientific journals or 
presented at scientific meetings, will not reveal your identity. 
13.Why have I been chosen to be in this study? 
a. Chosen because of grouping under the inclusion and exclusion criteria
b. Need of good sampling size 
c. No invasive procedure that harm your health and helps in diagnosis and 
helpful for the society 
14.How many people will be in the study? 254
15.Agreement of compensation to the participants (In case of a study related 
injury):
No related injury anticipated. Patient will be taken care in case of 
complication and   medical treatment will be provided. 
16.Anticipated prorated payment, if any, to the participant(s) of the study: 
Not applicable.
17.Can I withdraw from the study at any time during the study period? 
 The participation in this research is purely voluntary and you have the right 
to withdraw from this study at any time during the course of the study 
without giving any reasons.
 However, it is advisable that you talk to the research team prior to stopping 
information. 
18.If there is any new findings/information, would I be informed?  Yes
19.Expected duration of the participant’s participation in the study:
 1 day
20.Any other pertinent information:   
No other information
21.Whom do I contact for further information? 
Place:  
Date:      Signature of Principal Investigator 
Signature of the participant 
For any study related queries, you are free to contact :
Dr. Indu Krishna, 
Post graduate student, 
Department of oral Medicine and   Radiology 
Sree Mookambika Institute of  Dental  Sciences 
Kulasekharam,  KanyaKumari District-629161 
08129136826
mail2eindu@gmail.com 
PART 2 OF 2 
                 PARTICIPANTS CONSENT FORM 
The details of the study have been explained to me in writing and the details 
have been fully explained to me. I am aware that the results of the study may not be 
directly beneficial to me but will help in the advancement or medical sciences. I 
confirm that I have understood the study and had the opportunity to ask questions. I 
understand that my participation in the study is voluntary and that I am free to
withdraw at any time, without giving any reason, without the medical care that will
normally be provided by the hospital being affected. I agree not to restrict the use of 
any data or results that arise from this study provided such a use is only for scientific 
purpose(s). I have been given an information sheet giving details of the study. I fully 
consent to participate in the study titled: “Prevalence of Oral Health 
Complications in Type II Diabetes Mellitus Patients, A descriptive study” 
Serial no / Reference no:          
Name of the participant:      
Address of the participant: 
Contact number of the participant: 
Signature / thumb impression of the participant /  
Legal guardian 
Witnesses:       
1.
2.
Date:
Place:
 k½X ]{Xw þ `mKw þ 1  
]T\hpambn klIcn¡p¶ hyànIfpsS Adnhntebv¡v 
{]nbs¸« k¶² tkhItc,  
 R§Ä \n§sf kzmKXw sN¿p¶p.  AtXmsSm¸w Cu ]T\hpambn klIcn¡m\pÅ 
k¶²XtbmSv \n tcJs¸Sp¯p¶p.  \n§Ä Cu ]T\¯nÂ ]s¦Sp¡p¶Xn\p ap³]v Cu ]T\w  
F´n\mWv \S¯s¸Sp¶Xv F¶v AndtbXpv. AXn\mÂ Cu t^md¯nÂ  KthjW ]T\¯nsâ 
hnhc§fpw aäpw  hniZambn tcJs¸Sp¯nbncn¡p¶p.  Cu ]T\¯nsâ coXn, Dt±iw, {]tbmP\w, 
A]ISkm²yX, t¢iw, ap³IcpXÂ, F§s\ Cu ]T\w  ap³t]m«p sImpt]mIp¶p F¶n§s\  FÃm 
hnhc§fpw  t^md¯nÂ  tcJs¸Sp¯nbncn¡p¶p.  kZbw Cu  hnhc§Ä  hmbn¨p a\Ênem¡phm³  
A`yÀ°n¡p¶p.  Cu hnhc§fnÂ imkv{X]camb ]Z§Ä DÅXn\mÂ  kwib\nhmcW¯n\p {][m\ 
]T\IÀ¯mhnt\mtSm Xmsg tcJs¸Sp¯n bncn¡p¶ hyànItfmtSm t^mdw H¸nSp¶Xn\p ap³t]m 
AsÃ¦nÂ Cu ]T\¯nsâ Imemh[n Xocp¶Xphtctbm kao]n¡mhp¶XmWv.  
1. apJy KthjI³  :  tUm.Cp IrjvWm 
   aq¶mw hÀjw t]mÌp{KmPpthäv 
   Un¸mÀ«vsaâv Hm^v HmdÂ saUnkn³ & tdUntbmfPn,   
  {io aqImw_nI C³Ìnäyq«v Hm^v sUâÂ  kb³kv, 
   IpetiJcw þ 629 161. 
   {][m\ amÀ¤ZÀin  : tUm.ämäp tPmbv. C, Fw.Un.Fkv. 
   s{]m^kÀ & slUv Hm^v Zn Un¸mÀ«psaâv, 
   Un¸mÀ«vsaâv Hm^v HmdÂ saUnkn³ & tdUntbmfPn 
 {io aqImw_nI C³Ìnäyq«v Hm^v sUâÂ  kb³kkv, 
IpetiJcw. 
   kl amÀ¤ ZÀin  : tUm. iin Inc¬, Fw. Fw.Un.Fkv. 
   doUÀ 
   Un¸mÀ«vsaâv Hm^v HmdÂ saUnkn³ & tdUntbmfPn 
 {io aqImw_nI C³Ìnäyq«v Hm^v sUâÂ  kb³kkv, 
IpetiJcw. 
2. C³Ìnäyq«v : {io. aqImw_nI C³Ìnäyq«v Hm^v sUâvÂ  kb³kkv 
   ]S\new, IpetiJcw, I\ymIpamcn þ 629 161. 
  Xangv\mSv.  
3. ]T\ hnjbw:  
 {]tal tcmKnIfnÂ {]_eambpÅ hmb kw_Ôn¨n«pÅ k¦oÀWXIÄ hniZoIcn¡p¶ ]T\w. 
4.  ]T\¯nsâ ASnØm\w ? 
 cà¯nÂ ]©kmcbpsS Afhv IqSpt¼mgmWv HcmÄ {]tal tcmKnbmIp¶Xv.  CXn\p ImcWw 
H¶pInÂ C³kpen³ DÂ]mZ\¯n\pÅ A]cym]vXX AsÃ¦nÂ icoc¯nsâ tImi§Ä¡pw 
icnbmbn C³knent\mSv {]XnIcn¡m³ Ignbm¯XmWv. {]talw C¶v BtKmf P\XbpsS BtcmKy 
\nehmc¯nÂ DÂ¡WvT Dfhm¡p¶p. {]tal tcmKnIfpsS F®w Zn\w{]Xn DbcpIbmWv. 
IW¡pIÄ kqNn¸n¡p¶Xv 2030þÂ {]tal tcmKnIÄ  2000 BnepÅ 171 Zie£¯nÂ \n¶pw 366 
Zie£ambn Dbcp¶XmWv.  
5.  ]Tt\mt±iyw 
1) I\ymIpamcn PnÃbnepÅ Z´ÂtImtfPnÂ hcp¶ {]tal tcmKnIfpsS hmbnÂ km[mcWbmbn 
DmIp¶ tcmK§Ä F´msW¶v Ip]nSn¡pI.  
2) Gähpw IqSpXÂ hmbnepmIp¶ AkpJw GXmsW¶v a\Ênem¡pI.  
6.  ]T\s¯¡pdn¨pÅ imkv{X \ymboIcWw 
  {]talw F¶Xv A¶P¯ntâbpw sImgp¸ntâbpw, amwky¯nsâbpw Nbm]Nb¯nsâ 
tZmjIcamb hn«pamdm¯ AkpJamIp¶p.  Cu tcmK¯nsâ ^e§Ä  Zqsc hym]Ihpw AXv 
icoc¯nsâ Hmtcm tImi§fnepw ]t¯mfPn¡Â amä§Ä hcp¯pIbpw sN¿p¶p, AXn\mÂ FÃm 
Z´mtcmKy hnZKvZcpw Cu tcmKs¯¸änbpw  tcmK\nÀ®bs¯¸änbpw NnInÕbpw  tcmKw 
hcp¶Xns\ XSbp¶Xns\¸änbpw Adnªncn¡p ¶Xv tcmKnIÄ¡v \ÂIp¶ IcpXÂ 
sa¨s¸Sp¯p¶Xn\v \nÀ®mbIamWv.  
7.  ]T\coXn 
 ]T\w cp L«ambn \S¯p¶p.  BZyL«w hnhc§Ä {]taltcmKnIfnÂ \n¶v t\cn«v 
tiJcn¡p¶XmWv.  cmw L«w  hmbv ]cntim[\bpw Bhiysa¦nÂ XpSÀ ]cntim[\bpw 
\S¯p¶XmWv.  
8.  ]T\w aqew ]s¦Sp¡p¶ BÄ¡v DmIm³ CSbpÅ A]IS km[yX    þ  
               A]IS km²yX CÃ. 
9. tcmKnIÄ¡v {]Xo£n¡p¶ KpW§Ä ? 
 tcmKn Bhiys¸SpIbmsW¦nÂ Cu ]T\¯ns\mSphnÂ Gähpw \Ã NnInÕmcoXn 
\nÀt±in¡p¶XmWv. 
 
10.  hnhc§Ä clkyambn kq£n¡ptam ? AsX 
11.  Fs¶ F´psImv Cu ]T\¯nÂ DÄs¸Sp¯n ? 
  \n§Ä R§fpsS ]T\¯n\v A\ptbmPybmb LSI§Ä ]men¡s¸Sp¶ amXrIm]camb  
DZmlcWamIp¶p. Cu ]T\w aqew tcmK\nÀ®b¯n\v klmbhpw kaql¯n\v \·bpw {][m\w 
sN¿p¶p.  
12.  F{X BfpIÄ Cu ]T\¯nÂ DÄs¸Sp¶p.    254 
13.  ]T\w aqeapmIp¶ £X§Ä¡v \ã]cnlmc¯n\pÅ k½Xw ?   
]T\IÀ¯mhv NnInÕm sNehv hln¡p¶XmWv. 
14.  GsX¦nepw hn[¯nÂ thX\w e`n¡ptam    þ CÃ 
15.  Ft¸mÄ thWsa¦nepw  F\n¡v  Cu ]T\¯nÂ \n¶v  ]n·mdmtam þ kz´w 
XmÂ]cy{]Imcw Cu ]T\¯nÂ \n¶v Ft¸mÄthWsa¦nepw ]n·mdmhp¶XmWv ImcW§Â 
\ÂImsX Xs¶. F¶ncp¶mepw KthjW kwLt¯mSv ]n·mdp¶Xn\pap³]v kwkmcn¡phm³ R§Ä 
\n§tfmSv A`yÀ°n¡p¶p.  
16. Cu KthjW¯nsâ ^eambn ]pXnb Fs´¦nepw  Is¯epIfps¦nÂ 
AXv Fs¶ Andbn¡ptam ? AsX  
17. Cu ]T\¯nsâ  kab ssZÀLyw F{XbmWv ?   Hcp Znhkw 
18. CXnsâ `mKambn Fs´¦nepw  IqSpXÂ hnhc§Ä  th 
19. IqSpXÂ  hnhc§Ä¡mbn Xmsg ]dbp¶hsc \n§Ä¡v  _Ôs¸Smhp¶XmWv. 
 
    tUm.Cp IrjvWm 
    aq¶mw hÀjw t]mÌp{KmPpthäv 
    Un¸mÀ«vsaâv Hm^v HmdÂ saUnkn³ & tdUntbmfPn,   
    {io aqImw_nI C³Ìnäyq«v Hm^v sUâÂ  kb³kv, 
    IpetiJcw þ 629 161. 
                samss_Â \¼À : 8129136826 
    CþsabnÂ sFUn: mail2eindu@gmail.com 
   
 
 
Øew:           {]Ya At\zjIsâ H¸v 
 
XobXn :         
 
 
        ]s¦Sp¡p¶ Bfnsâ H¸v 
   
 
 
k½X]{Xw 
`mKw þ 2 
 
 Cu ]T\s¯ ]änbpÅ FÃm Imcy§fpw F\n¡v ]dªv a\Ênem¡n XcnIbpw AXnsâ Hcp 
]IÀ¸v F\n¡p \ÂIpIbpw sNbvXn«pv.  Cu ]T\w KthjW¯n\mbn DÅXmsW¶pw F\n¡v  CXnÂ 
\n¶v  t\cn«v  Hcp ^ehpw DmInsÃ¶pw Rm³ a\Ênem¡p¶p.  Cu ]T\¯nsâ  coXnbpw Dt±ihpw 
F\n¡v  a\Ênem¡n X¶n«pv.  AXp t]mse  F\n¡v kwib§Ä tNmZn¡m³  Ahkc§Ä  
e`n¨n«papv.  CXnÂ ]s¦Sp¡m\pw  ]s¦Sp¡mXncn¡m\pw  DÅ AhImiw  F\n¡ps¶pw  
AXpt]mse  ]T\¯nsâ GXp L«¯nepw  CXnÂ \n¶v ]n³h§m\pÅ kzmX{´yhpw F\n¡ps¶v  
Rm³ a\Ênem¡p¶p. Cu ]T\¯nÂ ]s¦Sp¡p¶Xp sImtm, ]s¦Sp¡m¯XpsImtm Fsâ aäp 
NnInÕIsf _m[n¡p¶XsÃ¶v Rm³  Andbp¶p.  
{]tal tcmKnIfnÂ {]_eambpÅ hmb kw_Ôn¨n«pÅ k¦oÀWXIÄ hniZoIcn¡p¶ 
]T\w F¶ KthjW¯nÂ ]s¦Sp¡p¶Xn\pw CXnsâ ^e§Ä imkv{XteJ\¯nÂ 
{]kn²oIcn¡p¶Xn\pw F\n¡v k½XamsW¶v Rm³ CXn\mÂ Andbn¨psImÅp¶p.  
 
kocnbÂ \¼À / d^d³kv \¼À : 
]s¦Sp¡p¶ Bfnsâ t]cv : 
taÂhnemkw : 
t^m¬ \¼À :  
 
                H¸v / 
hnceSbmfw 
km£n :   
   
     
Øew : 
XobXn  
   
 
 
 
 
Jl×Rp YôdÏêXm 
ØRp TôLm 
BWônf£«p TeÏùTßúYôÚdLô] RLYp Ï±l× 
 
AuTôokR TeúLtTô[oLú[, 
 CkR BWônf£«p ReLû[  DÓTÓj§dùLôs[ ªÏkR BoYjÕPu 
ØÝU]ÕPu LXkÕùLôs[ YkR YWúYtTô[oLû[ YWúYt¡ú\u.  ¿eLs CkR 
BWônf£«p  TeùLÓjÕdùLôsYRtÏ Øu CkR BWônf£ GRtLôL  
SPjRlTÓ¡\Õ GuTûR ùR°YôL ×¬kÕùLôs[úYiÓm. EeLÞdÏ  úRûYVô] 
Aû]jÕ  ®TWeLÞm ¸úZ ùLôÓdLlThÓs[Õ.   CkR BWônf£«u êXm  
HtTÓm  SuûULs, HúRàm  BTjÕLs Utßm ARtLôL Utßm GqYôß CkR 
BWônf£ úUtùLôs[lTÓm Øû\Lû[Ùm ùR¬®dLlThÓs[Õ.  C§p 
ùLôÓdLlThÓs[ ®TWeLû[ ùR°YôL T¥jÕ  ×¬kÕ ùLôs[úYiÓm.  ¿eLs  
BWônf£«p TeúLtTô[oL[ôL Jl×Rp  YZeÏYRtÏ  Øu×  EeLÞdÏ  HtTÓm  
A±®Vp NôokR NkúRLeLs Utßm  BWônf£ NmTkRlThP NkúRLeLs 
Aû]jÕm CkR BWônf£«u GkR LôXLhPj§Ûm ¿eLs T¥Yj§p Ï±l©hP 
ST¬Pm úLhÓ ùR°ÜTÓj§dùLôs[Xôm.  
 
1.  RûXûU BnYô[o :  PôdPo. CkÕ ¡ÚxQô 
 RÏ§   :  ØÕLûX (MDS) 
 ©¬Ü   :  K\p ùU¥£u & úW¥úVô[´ Õû\   
 ¨ßY]m :  c êLôm©Lô Cuv¥hëh Bl ùPuPp NVu^v, 
 CPm  :  ÏXúNLWm   
2. Y¯Lôh¥ :  PôdPo. PôhÓ ú_ôn. C, MDS. 
 RÏ§   :  úTWô£¬Vo & Õû\ úUXô[o 
 ©¬Ü   :  K\p ùU¥£u & úW¥úVô[´ Õû\   
 ¨ßY]m :  c êLôm©Lô Cuv¥hëh Bl ùPuPp NVu^v, 
 CPm  :  ÏXúNLWm 
3. CûQY¯Lôh¥ :  PôdPo. N£ ¡Wi. Gm, MDS. 
 RÏ§   :  ÃPo  
 ©¬Ü   :  K\p ùU¥£u & úW¥úVô[´ Õû\   
 ¨ßY]m :  c êLôm©Lô Cuv¥hëh Bl ùPuPp  NVu^v, 
 CPm  :  ÏXúNLWm  
 
4. Lpí¬   :  c êLôm©Lô Cuv¥hëh Bl ùPuPp NVu^v,  
TP¨Xm  
   ÏXúNLWmþ 629 161. 
5. BWônf£«u RûXl× 
  CWiPôm YûL ¿¬¯Ü úSô«]ôp  HtTÓm  A[ÜLû[ RÓdÏm 
Y¯Øû\Lû[ LiP±Ùm BnÜ. 
 
6. ©u]¦ RLYp:   
 ¿W¯Ü úSôn GuTÕ Y[o¡u\ Uôt\jRôp  HtTÓm úSôVôÏm.  CÕ 
CuÑu Ïû\Tôh¥]ôp  HtTÓYRôL SmTlTÓ¡\Õ.  CÕ úUÛm Li¥lTôL 
LûQVj§p Es[ BþùNp A¯®]ôp ApXÕ §ÑdL[ôp  CuÑû] HtL 
Ø¥VôR ¨ûX«p  HtTÓ¡\Õ.  EXL[®p ¿¬¯Ü úSô«û]l Tt±V ®¯l×QoÜ 
UdL°ûPúV HtThÓs[Õ.  RtúTôÕ ¿¬¯Ü úSô«]ôp AY§lTÓúYô¬u  
Gi¦dûL A§L¬jÕd ùLôiúP CÚd¡\Õ.   Hù]²p UdLs ùRôûL  A§L¬l×, 
ØÕûUVûPRp, EPp TÚUu Utßm  SLol×\ YôrÜ  B¡VûY LôWQeL[ôL 
AûU¡u\].  EXL[®p  ¿¬¯Ü úSô«]ôp Tô§dLlTÓúYô¬u  Gi¦dûL 171 
ªpV²p  CÚkÕ 366 ªV]ôL 2030þp CÚdÏm G] G§oTôodLlTÓ¡\Õ.  
7. ùLôsLs Utßm úSôdLeLs : 
i. ¿¬¯Ü  úSô«]ôp  Yôn NmTkRUô] Ïû\TôÓLs 
ii. L]A²VôÏU¬ UôYhPj§p  Es[ Tp UÚjÕY Lpí¬dÏ YÚm ¿¬¯Ü  
úSôVô°LÞdÏ HtTÓm  Yôn NmTkRUô] Ïû\TôÓLû[ LiP±Rp Utß 
×¬kÕ  ùLôsÞRp. 
iii. ¿¬¯Ü úSô«]ôp  HtTÓm  Yôn NmTkRUô] ®û[ÜL°u  ¾®WjûR 
LiP±Rp.  
8.  Bn®û]l Tt±V A±®Vp ®[dLm 
 ¿W¯Ü úSôn GuTÕ SôNWUô] A¯®dLdá¥V úSôn  CÕ 
LôoúTôûahúWh,ùLôÝl× Utßm ×WRj§u  Y[o£ûR Uôt\j§]ôp  HtTÓ¡\Õ.  
CÕ EPp Es[ Tp §ÑdL°p TpúYß Uôt\eLû[ HtTÓjÕ¡\Õ.  Tp ÑLôRôW 
T¦«p DÓTÓTYoLs úSô«û]  N¬VôL LiP±kÕ  AûR RÓdÏm 
Y¯Øû\Lû[Ùm.  AkR úSô«u  £¡fûNûVÙm úSôVô°LÞdÏ  AYoL°u 
¨ûXûV úUmTÓjRúYiÓm.  
9.  Bn®u ùNVpØû\   
 CkR BnYô]Õ CWiÓ ¨ûXL[ôL úUtùLôs[lTÓ¡\Õ.  
i. ØRp ¨ûXVô]Õ  RLYp úNL¬jRp BÏm.  CkR RLYpLs B]Õ 
Bn®p TeúLtTYoL°Pm  úLhÓ ùR¬kÕùLôssTÓ¡\Õ.  
ii. CWiPôYÕ ¨ûXVô]Õ úSW¥VôL Bn®p TeúLtTYoL°u Yô«û] 
ØÝûUVôL T¬úNô§jÕ  A±VlTÓjÕ¡\Õ.  
10. Bn®p LXkÕ ùLôsTYoLÞdÏ G§oTôodLlTÓm BTjÕLs ?    
G§oùLôs[lTÓm BTjÕLs úSôVô°«Pm ùR¬VlTÓjÕm. 
11 . TeúLtTô[oLÞdÏ G§oTôodLlTÓm  TVuLs?  
SpX JÚ UÚjÕYm úSôVô°dÏ A°dLlTÓm 
12 CWL£VjRuûU LôjRp  ?  
 EeL°Pm CÚkÕ úNL¬jR GkR ®TWØm CWL£VUôL ûYdLlTÓm. 
CRuêXm ¡ûPdÏm ×s°®TWm UhÓm ùY°«PlTÓm. Ut\T¥ R²ST¬u 
ùNôkR ®TWeLs ùY°«PlTPUôhPôÕ.  
13. GR]ôp CkR Bn®p Sôu TeúLtL úRokùRÓdLlThúPu  ?   
 A, G]Õ Lp® ¨ßY]j§u ¨TkRû]LÞdÏ  CÕ EhThPÕ. 
 B. úSônL°u BnÜ 
 C. GkR YûL«Ûm úSôVô°Lû[ ªÏkR £WUj§tÏ EhTÓjRôÕ.  
14. CkR Bn®p GjRû]úTo TeúLt¡\ôoLs ?            254 
15. CkR Bn®u êXm HúRàm ©u®û[ÜLs HtThPôp BWônf£Vô[o ùTôßl× 
HtTôWô? 
          BWônf£Vô[o ùTôÚ[ôRôW A[®p ùTôßlúTtTôo. 
16. CkR BWônf£«p TeÏùTßúYôÚdÏ Gq®R ùRôûLÙm YZeLlTÓUô ?    
CpûX 
17. Sôu CkR BWônf£«ÚkÕ ®ÚlTlThPôp GkR LôXLhPj§Ûm ®XLXôUô?      
úSôVô°«u GkR JÚ LhÓlTôÓ / ¨TkRû]L°u ¸r CkR Bn®tÏ 
EhTÓjRlTP®pûX. AYoL°u ØÝ JjÕûZl× Utßm NmURj§u úT¬p UhÓúU 
TeùLÓjÕs[]o.    
18. HúRàm ×§V ùNn§, ×§V LiÓ©¥l× Tt± Sôu A±®dLlTÓúY]ô?     Bm 
19. BWônf£«u G§oTôodLlTÓm  TeÏLôX A[Ü?      JÚ Sôs 
20. úYß HúRàm  ùTôÚjRUô] ®TWeLs EiPô?  CpûX 
21. CqYôWônf£ûVl Tt±V ®YWeLû[ Vô¬Pm úLhÓ ùR¬kÕdùLôsYÕ? 
                  PôdPo. CkÕ ¡ÚxQô 
 ØÕLûX (MDS) 
 K\p ùU¥£u & úW¥úVô[´ Õû\   
 c êLôm©Lô Cuv¥hëh Bl ùPuPp NVu^v, 
 ÏXúNLWm 
 Cell: 8129136826 ,  Email: mail2eindu@gmail.com 
CPm : 
úR§ :      ØRuûU BWônf£Vô[¬u  
          
       ûLùVôlTm 
Jl×Rp T¥Ym 
TôLm-2 
 
 CkR BWônf£«u RLYpLs Aû]jÕm Gu²Pm ùR°YôL GÝjÕ êXm 
®[dLlThÓs[Õ. CkR BWônf£«u Ø¥ÜLs G]dÏ úSW¥VôL 
TVuTWô®hPôÛm UÚjÕYjÕû\«u  Øuú]t\j§tÏ  TVuTÓm  GuTûR 
A±úYu.  CqYôWôn£ûVl Tt± Sôu ùR°YôL ×¬kÕd ùLôiÓsú[u. Sôu 
Rô]ôL ØuYkÕ C§p TeÏl ùTß¡ú\u. GuTûR A±úYu. C§ÚkÕ GkR 
úSWØm GdLôWQØm á\ôUp YkRôÛm CkR UÚjÕYUû]«p G]dÏ  
¡ûPdÏm UÚjÕY ER® Gq®Rj§Ûm Tô§dLlTPôÕ GuTûRÙm A±úYu. 
CqYôWônf£«u êXm YÚm Ø¥ÜLs Utßm RLYpLû[  A±®VpÕû\«u  
TVuTôÓLÞdÏ  (UhÓúU) ETúVôLlTh¥dùLôs[ NmU§d¡ú\u. G]dÏ  
CqYôWônf£ûVl Tt±V  ®¬Yô] RLYpLs APe¡V  T¥Ym RWlThÓs[Õ.  
 Sôu “CWiPôm YûL ¿¬¯Ü úSô«]ôp HtTÓm Yôn NmUkRUô] 
®û[ÜLû[ RÓdÏm Y¯Øû\Lû[ LiP±Ùm BnÜ ” Gu¡\ BWônf£«p  
TeúLtL ØÝU]ÕPu  NmU§d¡ú\u.  
 
TeÏ ùLôsTY¬u ùRôPo, UÚjÕY Gi : 
TeÏ ùLôsTY¬u ùTVo           : 
18 YV§tÏ ¸r Es[YoLÞdÏ TôÕLôYX¬u ûLùVôlTm: 
ØLY¬  
ùRôûX ùRôPo× Gi : 
TeÏ ùLôsTYo TWôU¬lTYo ûLùVôlTm/ùTÚ®Wp ÑYÓ : 
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SREE MOOKAMBIKA INSTITUTE OF DENTAL SCIENCE 
DEPARTMENT OF ORAL MEDICINE AND RADIOLOGY 
Prevalence of Oral Health Complications in Type II Diabetes mellitus patients: 
A Descriptive study 
CASE SHEET
PROFORMA FOR ASSESSING ORAL HEALTH PROBLEMS IN 
TYPE II DIABETES PATIENTS 
        
Op no 
Name- 
Age    - 
Sex    - 
Occupation-
Address-
Socioeconomic Status- 
Chief complaint- 
Medication/Treatment- 
 Medical history- 
 Dental history   - 
Oral hygiene- Good/Fair/Poor
   
Dentition status
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
                
                
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                          
Caries- DMF INDEX 
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
                
                
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
0 - sound tooth  6 - sealant, varnish
1 - decayed tooth  7 - bridge, crown
2 - filled and decayed  8 - unerupted tooth
3 - filled without decay  9 - excluded tooth
4 - missing due to caries  T - trauma(fracture)
5 - missing due to other reasons     
Periodontal status- CPITN INDEX 
Bleeding:
17 16 21 26 27 
47 46 41 36 37 
0 - Absent,  1 - Present,   9 - Tooth excluded,    x - Tooth not present 
Pocket depth:
17 16 21 26 27 
47 46 41 36 37 
0 - Absent,  1-Pocket 4-5mm,     2- Pocket 6mm or more, 
9- Tooth excluded,     x- Tooth not present 
Attachment loss-                              
17 16 21 26 27 
47 46 41 36 37 
0) 0-3mm        1) 4-5mm           2) 6-8mm         3) 9-11mm           
4) 12mm or more       9) Not recorded         X) Excluded 
Candidiasis
1. Acute pseudomembranous
2. Acute atrophic/antibiotic sore mouth
3. Chronic atrophic / denture stomatitis
4. Angular chelitis
5. Chronic hyperplastic
  Ulceration –       Site         
        Size         
        Acute/Chronic/Recurrent       
Taste Alteration (dysgeusia)   
NCI common terminology criteria for adverse events -  
Grade I-Altered taste but no change in diet
Grade II-Altered taste with change in diet (e.g., oral supplements); noxious or 
unpleasant taste; loss of taste. 
Grade 1 Grade 2 
Burning Mouth Syndrome 
DN4 Questionnaire for Burning mouth syndrome 
INTERVIEW OF THE PATIENT 
Question 1: Does the pain have one or more of the following characteristics? 
1 – Burning
2 – Painful cold                  
3 – Electric shocks 
Question 2: Is the pain associated with one of more of the following symptoms in 
the same area? 
4 – Tingling 
5 – Pins and needles 
6 – Numbness 
7 – Itching 
EXAMINATION OF THE PATIENT 
Question 3: Is the pain located in an area where the physical examination may 
reveal one or more of the following characteristics? 
8 – Hypoesthesia to touch
9 – Hypoesthesia to prick
Question 4: In the painful area, can the pain be caused or increased by: 
10 – Brushing
              Score Yes 1                         No 0
Total: The total score is calculated as the sum of the 10 items and the cut-off value 
for the diagnosis of neuropathic pain is a total score of 4/10. 
Any other observations? 
